Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000993207 | SCV001146010 | uncertain significance | not provided | 2018-10-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002550656 | SCV003512860 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2022-07-18 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 3172 of the SYNE1 protein (p.Glu3172Asp). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C35"). ClinVar contains an entry for this variant (Variation ID: 805590). This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. This variant is present in population databases (rs6913579, gnomAD 0.004%). |
Ce |
RCV000993207 | SCV004160583 | uncertain significance | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | SYNE1: PM2, BP4 |